{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:31:43Z","timestamp":1791919903863,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T00:00:00Z","timestamp":1575417600000},"content-version":"vor","delay-in-days":3,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Cytomegalovirus infection dramatically decreased with the introduction of antiretroviral therapy. Whether incidence, clinical characteristics and prognosis of cytomegalovirus in HIV infected patients, has changed over time is. scarcely known.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Retrospective single-center study. Patients included in this study were all HIV infected patients that went to our center for any disease, and were diagnosed with cytomegalovirus, during the period 2004\u20132015. epidemiological, clinical and laboratory patients variables were collected in a clinical database. Clinical characteristics, incidence of cytomegalovirus and predictors of mortality during the study were assessed. Results were considered statistically significant when <jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05. All statistical analyses were calculated by SPSS version 20.0 (Chicago, IL,USA).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Fifty-six cases of cytomegalovirus infection, in HIV infected patients were identified during the study period (incidence rate-1.7 cases per 1000 persons\/year). The most frequent presentation was systemic illness in 43% of cases. Of note,no patients presented with ophthalmic manifestations. The 30-days mortality was 18%. Predictors of mortality were, in the univariate analysis, admission to the intensive care unit OR 32.4 (3.65\u2013287.06) <jats:italic>p<\/jats:italic>\u00a0=\u00a00.0001, and mechanic ventilation 84 OR (8.27\u2013853.12) p\u2009=\u00a00.0001, and ART OR 4.1 (0.97\u201317.31) <jats:italic>p<\/jats:italic>\u00a0=\u00a00.044. These variables were assessed by multivariate analysis, and only mechanical ventilation was statistically significant (<jats:italic>p<\/jats:italic>\u00a0&lt;\u00a00.05)<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Incidence of cytomegalovirus infection was higher than described in the antiretroviral therapy era. Clinical presentation has changed. Mechanic ventilation predicted mortality.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-019-4643-6","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:03:28Z","timestamp":1575486208000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy"],"prefix":"10.1186","volume":"19","author":[{"given":"R.","family":"Perello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Monclus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Saubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Inciarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mallolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. A.","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,4]]},"reference":[{"key":"4643_CR1","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","volume":"11","author":"NF Crum","year":"2006","unstructured":"Crum NF, Riffenburg RH, Wegner S, Agan BK, Tasker SA, et al. Comparisons of causes of death and mortality rates aamong HIV-infected persons: analysis of the pre-, early, and late HAART eras. J Acquir Immune Defic Syndr. 2006;11:194\u2013200.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4643_CR2","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/00002030-199611000-00009","volume":"10","author":"EF Bowen","year":"1996","unstructured":"Bowen EF, Griffiths PD, Davey CC, Emery VC, Johnson MA. Lessons from the natural history of cytomegalovirus. AIDS. 1996;10:S37\u201341.","journal-title":"AIDS"},{"key":"4643_CR3","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/00042560-199604150-00006","volume":"11","author":"DH Shepp","year":"1996","unstructured":"Shepp DH, Moses JE, Kaplan MH. Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival. J Acquir Immune Defic Syndr. 1996;11:460\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"4643_CR4","doi-asserted-by":"crossref","unstructured":"Lurain NS, Hanson BA, Hotton AL, Weber KM, Cohen MH, Landay AL. The association of human cytomegalovirus with biomarkers of inflamation and immune activation in HIV-1-infected women. AIDS Res Hum Retrovir. 2015;22 [Epub ahead of print].","DOI":"10.1089\/aid.2015.0169"},{"issue":"3","key":"4643_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00430-015-0415-0","volume":"204","author":"JG Sissons","year":"2015","unstructured":"Sissons JG, Willis MR. How understanding immunology contributes to managing CMV disease in immunosuprpessed patients: now and in future. Med Microbiol Immunol. 2015;204(3):307\u201316.","journal-title":"Med Microbiol Immunol"},{"key":"4643_CR6","doi-asserted-by":"crossref","unstructured":"d\u2019Arminio Monforte A, Mainini F, Testa L, Vago L, Balotta L, et al. Predictors of cytomegalovirus disease, natural history and autopsy findings in a cohort of patients with AIDS. 1997;11:517\u201324.","DOI":"10.1097\/00002030-199704000-00016"},{"key":"4643_CR7","first-page":"629","volume":"61","author":"RB Podlasin","year":"2007","unstructured":"Podlasin RB. CMV infection in HIV-patients. Przegl Epidemiol. 2007;61:629\u201337.","journal-title":"Przegl Epidemiol"},{"key":"4643_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1001\/jama.283.5.653","volume":"283","author":"SM Whitcup","year":"2000","unstructured":"Whitcup SM. Cytomegalovirus retinitis in the era of highly antirretroviral therapy. JAMA. 2000;283:653\u20137.","journal-title":"JAMA"},{"key":"4643_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1590\/S1413-86702007000100039","volume":"11","author":"S Majumder","year":"2007","unstructured":"Majumder S, Mandal SK, Bandyopadhyay D, Chowdhury SR, Chakraborty PP, Mitra K. Multiorgan involvement due to cytomegalovirus infection in AIDS. Braz J Infect Dis. 2007;11:176\u20138.","journal-title":"Braz J Infect Dis"},{"key":"4643_CR10","doi-asserted-by":"publisher","first-page":"466","DOI":"10.2174\/187152611797636703","volume":"11","author":"SA Ross","year":"2011","unstructured":"Ross SA, Novak Z, Boppana SB. Diagnosis of cytomegalovirus infections. Infect Disord Drug Targets. 2011;11:466\u201374.","journal-title":"Infect Disord Drug Targets"},{"key":"4643_CR11","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1093\/cid\/cis212","volume":"54","author":"CS Kraft","year":"2012","unstructured":"Kraft CS, Armstrong WS, Caliendo AM. Interpreting quatitative cytomegalovirus DNA testing: understanding the laboratory perspective. Clin Infect Dis. 2012;54:1793\u20137.","journal-title":"Clin Infect Dis"},{"key":"4643_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","volume":"96","author":"CN Kotton","year":"2013","unstructured":"Kotton CN, Kumar D, Caliendo AM, Asberg A, Chou S, Danziger-Isakov L, et al. Transplantation Society International CMV Consensus Group. Update international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2013;96:333\u201360.","journal-title":"Transplantation"},{"key":"4643_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/cid\/ciw668","volume":"64","author":"P Ljungman","year":"2017","unstructured":"Ljungman P, Boeckh M, Hirsch HH, Josephson F, Lundgren J, Nichols G, et al. Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials. Clin Infect Dis. 2017;64:87\u201391.","journal-title":"Clin Infect Dis"},{"key":"4643_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-016-0517-4","volume":"14","author":"S George","year":"2016","unstructured":"George S, Bergin C, Clarke S, Courtney G, Codd MB. Health-related quality of life and associated factors in people with HIV: an Irish cohort study. Health Qual Life Outcomes. 2016;14:115.","journal-title":"Health Qual Life Outcomes"},{"key":"4643_CR15","doi-asserted-by":"publisher","first-page":"10403","DOI":"10.1086\/514738","volume":"28","author":"N Rabella","year":"1999","unstructured":"Rabella N, Rodriguez P, Labeaga R, Otegui M, Mercader M, Gurgu\u00ed M, et al. Convencional respiratory recovered from immunocompromised patients: clinical considerations. Clin Infect Dis. 1999;28:10403\u20131048.","journal-title":"Clin Infect Dis"},{"key":"4643_CR16","unstructured":"The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 6.0, 2016. http:\/\/www.eucast.org."},{"key":"4643_CR17","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1097\/00002030-199908200-00009","volume":"13","author":"JL Casado","year":"1999","unstructured":"Casado JL, Arrizabalaga J, Montes M, Mart\u00ed-Belda P, Tural C, Pinilla J, et al. Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor theraphy. Spanish CMV-AIDS Study Group. AIDS. 1999;13:1497\u2013502.","journal-title":"AIDS"},{"key":"4643_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s15010-005-5050-z","volume":"33","author":"B Alzberger","year":"2005","unstructured":"Alzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, W\u00f6hrmann A, et al. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection. 2005;33:345\u20139.","journal-title":"Infection"},{"key":"4643_CR19","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/2229-516X.157166","volume":"5","author":"K Ramesh","year":"2015","unstructured":"Ramesh K, Gandhi S, Rao V. Clinical profile of human immunodeficiency virus patients with opportunistic infections: A descriptive case series study. Int J Appl Basic Med Res. 2015;5:119\u201323.","journal-title":"Int J Appl Basic Med Res"},{"key":"4643_CR20","first-page":"31","volume":"79","author":"TE Vasil\u2019eva","year":"2007","unstructured":"Vasil\u2019eva TE, Litinova NG, Shaklhgil\u2019dian VI, Ol\u2019shank\u00ef A, Fillippoy PG, Morozova SV, et al. Pulmonary diseases in patients with HIV infection. Ter Arkh. 2007;79:31\u20135.","journal-title":"Ter Arkh"},{"key":"4643_CR21","first-page":"37","volume":"77","author":"S Oka","year":"2002","unstructured":"Oka S. Pulmonary complications in pacients with AIDS. Kekkaku. 2002;77:37\u201340.","journal-title":"Kekkaku"},{"key":"4643_CR22","first-page":"641","volume":"4","author":"AV Loo","year":"2011","unstructured":"Loo AV, Sujaya S, Peyman M, Florence S, Subrayan V. Retinal manifestations of patients with immunodeficiency virus, a multiethnics study in Malaysia. Int J Ophthalmol. 2011;4:641\u20133.","journal-title":"Int J Ophthalmol"},{"key":"4643_CR23","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ophtha.2015.02.033","volume":"122","author":"DA Jabs","year":"2015","unstructured":"Jabs DA, Ahuja A, Van Natta ML, Lyon AT, Yeh S, Danis R, et al. Long-term outcomes of cytomegalovirus retinitis in the era of modern antiretroviral therapy: results from a United States cohort. Ophthalmology. 2015;122:1452\u201363.","journal-title":"Ophthalmology"},{"key":"4643_CR24","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.ophtha.2006.11.008","volume":"114","author":"DA Jabs","year":"2007","unstructured":"Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL, Davis MD, et al. Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology. 2007;114:780\u20136.","journal-title":"Ophthalmology."},{"key":"4643_CR25","doi-asserted-by":"publisher","first-page":"7546","DOI":"10.1167\/iovs.12-10349","volume":"53","author":"SC Teoh","year":"2012","unstructured":"Teoh SC, Wang PX, Wong EP. The epidemiology and incidence of cytomegalovirus retinitis in the HIV population in Singapore over 6 years. Invest Ophthalmol Vis Sci. 2012;53:7546\u201352.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"4643_CR26","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3389\/fmicb.2015.01016","volume":"6","author":"E Adland","year":"2015","unstructured":"Adland E, Klenerman P, Goulder P, Matthews PC. Ongoing burden of disease from HIV\/CMV coinfection in Africa in the antirretroviral theraphy era. Front Microbiol. 2015;6:1016.","journal-title":"Front Microbiol"},{"key":"4643_CR27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/COH.0000000000000241","volume":"11","author":"A Boulougoura","year":"2016","unstructured":"Boulougoura A, Sereti I. HIV infection and immune activation: the role of coinfections. Curr Opin HIV AIDS. 2016;11:191\u2013200.","journal-title":"Curr Opin HIV AIDS"},{"key":"4643_CR28","first-page":"159","volume":"147","author":"R Carrillo Esper","year":"2011","unstructured":"Carrillo Esper R. Citomegalovivirus reactivation in critical ill intensive care patients. Gac Med Mex. 2011;147:159\u201362.","journal-title":"Gac Med Mex"},{"key":"4643_CR29","doi-asserted-by":"publisher","first-page":"e75915","DOI":"10.1371\/journal.pone.0075915","volume":"8","author":"J Xiao","year":"2013","unstructured":"Xiao J, Gao G, Li Y, Zhang W, Tian Y, Huang Y, Su W, Han N, et al. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China. PLoS One. 2013;8:e75915.","journal-title":"PLoS One"},{"key":"4643_CR30","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s00134-015-4066-9","volume":"42","author":"L Apazian","year":"2016","unstructured":"Apazian L, Hraiech S, Lehingue S, Roch A, Chiche L, Wiramus S. Cytomegalovirus reactivation in ICU patients. Intensive Care Med. 2016;42:28\u201337.","journal-title":"Intensive Care Med"},{"key":"4643_CR31","doi-asserted-by":"publisher","first-page":"e93702","DOI":"10.1371\/journal.pone.0093702","volume":"9","author":"SH Mayaphi","year":"2014","unstructured":"Mayaphi SH, Brauer M, Morobadi DM, Mazanderani AH, Mafuyeka RT, Olorunju SA, et al. Cytomegalovirus viral load kinetics in patients with HIV\/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapy. PLoS One. 2014;9:e93702.","journal-title":"PLoS One"},{"key":"4643_CR32","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/infdis\/jiu417","volume":"211","author":"M Lichtner","year":"2015","unstructured":"Lichtner M, Cicconi P, Vita S, Cozzi-Lepri A, Galli M, Lo Caputo S, et al. Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients. J Infect Dis. 2015;211:178\u201386.","journal-title":"J Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4643-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4643-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4643-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T01:04:27Z","timestamp":1606957467000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4643-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4643"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4643-6","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"19 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics and Research Committee of Hospital Cl\u00ednic, Barcelona. Written informed consent was obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1030"}}